Acknowledged: the committee has received your protocol and it will now be sent out for review to Board members.

Administrative Hold: An action to temporarily stop data collection and analysis on a project. This is a voluntary action by the Principal Investigator.

Amendments: Amendments are changes that the researcher wishes to make after a study is approved by the Committee. The researcher must submit an Amendment/Modification Package for Committee approval.

Co-Principal Investigator (Co-PI): The other primary scholar or researcher involved in conducting the research; if the project is for a thesis or dissertation, the student is the Co-PI.

Designated Reviewer: The committee chair or an experienced committee member designated by the committee chair to conduct Non-Committee Reviews.

Experienced Member: A compliance committee member is considered experienced if the respective compliance committee chair considers the member to have sufficient experience in and knowledge of conducting research compliance reviews.

Full Board Review: Review of proposed research at a convened meeting at which a majority of the membership of the compliance committee are present, including at least one member whose primary concerns are in nonscientific areas. For the research to be approved, it must receive the approval of a majority of those members present at the meeting. Generally, studies that undergo full board review are studies involving greater than minimal risk, risky, novel procedures, or vulnerable populations.

Institutional Animal Care and Use Committee (IACUC): A body specifically constituted as required in 9 CFR 2.31 which provides review and approval of animal use activities, and inspection of animal facilities. The principal investigator (PI) or instructor, and their staff, are responsible for understanding and following the regulations, as well as institutional policies, governing animal care and use.

Institutional Biosafety Committee (IBC): A body specifically constituted as required in 49 CFR 171 which conducts (1) the initial review and approval and (2) the continuing review of research involving recombinant DNA. These reviews are conducted in accordance with the provisions of the NIH Guidelines for Research Involving Recombinant DNA.

Modification: Any change to a committee approved study protocol, regardless of the level of review it receives initially.

Non-Affiliated Member: An compliance committee member who is not, and whose immediate family members are not, affiliated with the university appointment on the respective compliance committee.

Protocol: The scientific plan of the research study. A protocol describes the purpose of the study, who is eligible to participate, details about the research procedures, the length and steps of the study, and what information will be gathered.

Sponsor: The organization that oversees and pays for the study or provides in-kind support (like medications). This can be a single person, a charitable foundation, a medical institution, a drug-making company, or a federal agency like the National Institutes of Health or Department of Defense.